Moderna, Inc.(MRNA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

MRNA Moderna, Inc.

休市中 01-30 16:00:00 EST

44.07

-2.79

-5.95%

盘后43.70

-0.37-0.84%

19:59 EST

最高46.34	最低43.43	成交量1,096万
今开45.98	昨收46.86	日振幅6.21%
总市值172.17亿	流通市值160.10亿	总股本3.91亿
成交额4.86亿	换手率3.02%	流通股本3.63亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"MRNA","market":"US","secType":"STK","nameCN":"Moderna, Inc.","latestPrice":44.07,"timestamp":1769806800000,"preClose":46.86,"halted":0,"volume":10960675,"hourTrading":{"tag":"盘后","latestPrice":43.7,"preClose":44.07,"latestTime":"19:59 EST","volume":477455,"amount":21035353.0393,"timestamp":1769821174591,"change":-0.37,"changeRate":-0.008396,"amplitude":0.009503},"delay":0,"changeRate":-0.05953905249679896,"floatShares":363290461,"shares":390679512,"eps":-8.051605,"marketStatus":"休市中","change":-2.79,"latestTime":"01-30 16:00:00 EST","open":45.98,"high":46.3399,"low":43.43,"amount":486232312.83275,"amplitude":0.062098,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-8.051605,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1770022800000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1544158800000,"exchange":"NASDAQ","adjPreClose":46.86,"preHourTrading":{"tag":"盘前","latestPrice":45.95,"preClose":46.86,"latestTime":"09:29 EST","volume":29648,"amount":1361764.541248,"timestamp":1769783350408,"change":-0.91,"changeRate":-0.01942,"amplitude":0.025395},"postHourTrading":{"tag":"盘后","latestPrice":43.7,"preClose":44.07,"latestTime":"19:59 EST","volume":477455,"amount":21035353.0393,"timestamp":1769821174591,"change":-0.37,"changeRate":-0.008396,"amplitude":0.009503},"volumeRatio":0.8071387587135503,"optionData":{"bulkOrders":[{"symbol":"MRNA","call":true,"expireDate":1773979200000,"strike":"47.0","timestamp":1769802017441,"price":4.2,"volume":8000,"amount":3360000,"type":"+"},{"symbol":"MRNA","call":true,"expireDate":1771563600000,"strike":"47.0","timestamp":1769802017439,"price":2.5,"volume":8000,"amount":2000000,"type":"+"}]},"impliedVol":0.9965,"impliedVolPercentile":0.9801},"requestUrl":"/m/hq/s/MRNA","defaultTab":"news","newsList":[{"id":"1124407611","title":"异动解读 | 首席医疗官卸任引发市场担忧，Moderna盘中大跌5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=1124407611","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1124407611?lang=zh_cn&edition=full","pubTime":"2026-01-31 00:03","pubTimestamp":1769789003,"startTime":"0","endTime":"0","summary":"Moderna股价今日盘中出现大幅下跌，跌幅达5.05%，引起了投资者的广泛关注。消息面上，此次股价波动与公司高层人事变动直接相关。Moderna公司宣布，其首席医疗官杰奎琳·米勒将于3月2日卸任。根据公司公告，米勒卸任后将继续担任顾问以协助过渡，同时公司已任命大卫·伯曼为首席开发官。尽管如此，市场对此重大人事调整的反应依然消极，导致了股价在交易时段内承压下行。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["MRNA"],"gpt_icon":0},{"id":"1195523505","title":"Recordati协议条款：Moderna可获商业与销售里程碑付款及年度净销售额分层版税","url":"https://stock-news.laohu8.com/highlight/detail?id=1195523505","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1195523505?lang=zh_cn&edition=full","pubTime":"2026-01-30 06:28","pubTimestamp":1769725712,"startTime":"0","endTime":"0","summary":"根据Recordati与Moderna, Inc.达成的合作协议条款，Moderna, Inc.除享有其他权益外，还有资格获得基于商业和销售表现的里程碑付款。此外，协议还规定了按年度净销售额计算的分层版税制度，随着销售额的提升，版税比例将相应调整。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"b1d10af39e3603a6f0c840ebceb83a8d","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","BK4551","BK4588","MRNA","BK4534","BK4568","BK4533","BK4139","BK4548","BK4585","BK4501"],"gpt_icon":0},{"id":"1140227198","title":"一周美股牛榜 | Moderna上周升逾16%，投资者寄望于一款癌症疫苗试验；Sandisk上周跃升逾14%，内存和数据存储领域需求强劲且供应有限","url":"https://stock-news.laohu8.com/highlight/detail?id=1140227198","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1140227198?lang=zh_cn&edition=full","pubTime":"2026-01-26 10:20","pubTimestamp":1769394049,"startTime":"0","endTime":"0","summary":"花旗重申对Sandisk的买入评级，并将其目标价从280美元上调至490美元，理由是内存和数据存储领域需求强劲且供应有限。该股上周上涨12%。EQT股价上周上涨9.9%。自年初以来，黄金已上涨15%。","market":"us","thumbnail":"https://community-static.tradeup.com/news/b709e81a1b4f7405bf5e343b3c9425a7","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/b709e81a1b4f7405bf5e343b3c9425a7"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"82124819a92bd30e39cc6bade83fa1ee","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMD","MRNA","MU","EQT","SNDK"],"gpt_icon":0},{"id":"1147313320","title":"异动解读 | Moderna盘中大跌7.42%，因宣布不投资新后期疫苗试验","url":"https://stock-news.laohu8.com/highlight/detail?id=1147313320","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1147313320?lang=zh_cn&edition=full","pubTime":"2026-01-23 22:42","pubTimestamp":1769179350,"startTime":"0","endTime":"0","summary":"Moderna, Inc.（MRNA）今日盘中股价大幅下跌7.42%，引起了市场的广泛关注。消息面上，该公司首席执行官在达沃斯论坛上宣布，由于美国官员对疫苗的反对声浪日益高涨，公司不打算投资新的后期疫苗试验。这一决定可能影响其未来产品管线的发展和收入增长前景，导致投资者信心受挫。作为一家专注于信使RNA技术的生物技术公司，Moderna此前凭借新冠疫苗获得了显著的成功。此次宣布暂停对后期疫苗试验的投资，引发了市场对其未来增长动力的担忧，从而导致了股价的急剧下跌。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"f70e37af5f5b7cb9e4660871dd5a04c8","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["MRNA"],"gpt_icon":0},{"id":"1104432696","title":"美股夜盘 | 存储概念股续涨，SanDisk、西部数据涨超2%；Moderna续涨逾5%，该股隔夜飙涨近16%","url":"https://stock-news.laohu8.com/highlight/detail?id=1104432696","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1104432696?lang=zh_cn&edition=full","pubTime":"2026-01-22 09:03","pubTimestamp":1769043819,"startTime":"0","endTime":"0","summary":"1月22日，美股夜盘时段，存储概念股续涨，SanDisk、西部数据涨超2%，美光科技、希捷科技涨超1%；Rocket Lab跌超4%，此前宣布其Neutron火箭系统结构极限测试中出现故障;Moderna续涨超5%，该股隔夜飙涨近16%！mRNA癌症疫苗联合疗法2b结果公布，复发或死亡风险近半；游戏驿站涨超5%，CEO斥资增持50万股，持股比例升至9.2%。","market":"us","thumbnail":"https://static.tigerbbs.com/5d1fe578ee46cbe0d24c33435ff25ae5","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/5d1fe578ee46cbe0d24c33435ff25ae5"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"383e1462b8f78ae45e6c97ca799f945c","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0444973449.USD","LU0444971666.USD","LU1069347547.HKD","LU0081259029.USD","MRNA","LU1046421795.USD","LU0957808578.USD","WDC","BK4585","SNDK","LU1823568750.SGD","LU1035773651.USD","LU0476273544.USD","LU0006061336.USD","LU1815336760.USD","GB00BDT5M118.USD","BK4170","BK4588","LU1235294995.USD","BK4512","LU1642822529.SGD"],"gpt_icon":0},{"id":"1113767213","title":"Moderna个体化mRNA癌症疫苗联合疗法5年随访积极结果公布","url":"https://stock-news.laohu8.com/highlight/detail?id=1113767213","media":"药明康德","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1113767213?lang=zh_cn&edition=full","pubTime":"2026-01-22 04:14","pubTimestamp":1769026479,"startTime":"0","endTime":"0","summary":"Moderna和默沙东今日公布了2b期KEYNOTE-942/mRNA-4157-P201研究的中位五年随访数据。分析显示，在中位随访5年时，与Keytruda单药相比，intismeran autogene与Keytruda联合疗法持久降低患者的复发或死亡风险近半。研究中intismeran autogene联合Keytruda的安全性特征与此前报告保持一致。Moderna和默沙东计划在即将召开的医学会议上公布主要和次要终点随访分析的进一步数据。一项用于肾细胞癌辅助治疗的随机2期研究已完成入组。","market":"us","thumbnail":"https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://mp.weixin.qq.com/s/jOPVre6DJEmwh9Q-5LQOMg","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Moderna个体化mRNA癌症疫苗联合疗法5年随访积极结果公布","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"lsy1604035543434","symbols":["MRNA"],"gpt_icon":1},{"id":"1153320176","title":"Moderna发布Intismeran Autogene联合Keytruda五年数据：主要终点指标持续改善","url":"https://stock-news.laohu8.com/highlight/detail?id=1153320176","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1153320176?lang=zh_cn&edition=full","pubTime":"2026-01-20 19:14","pubTimestamp":1768907652,"startTime":"0","endTime":"0","summary":"Moderna, Inc.公布的最新五年随访数据显示，其研发的Intismeran Autogene与默沙东的Keytruda（帕博利珠单抗）联合疗法，在主要临床终点指标上展现出持续性的改善效果。这一长期研究结果进一步验证了该组合疗法在相应适应症中的治疗潜力与持久性优势。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"af6d5978dd8ba0577467648f22d69ae3","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BJT1NW94.SGD","LU0006306889.USD","IE00BLSP4239.USD","LU2361045086.USD","LU0265550946.USD","LU1941712264.USD","LU2023250843.SGD","BK4534","IE0002141913.USD","LU1066051225.USD","IE00B2B36J28.USD","LU1934455194.USD","LU1934455277.USD","LU0965509101.SGD","LU1069347547.HKD","LU2125154778.USD","LU0106261372.USD","LU0208291251.USD","IE00BBT3K403.USD","LU0477156953.USD","MRNA","IE00BJJMRZ35.SGD","IE000M9KFDE8.USD","LU1035773651.USD","LU2023250504.SGD","LU2112291526.USD","BK4007","IE00B4R5TH58.HKD","LU1430594728.SGD","LU0648001328.SGD","LU1585245621.USD","LU1066051498.USD","BK4585","SG9999014567.USD","LU0965508806.USD","LU2360032135.SGD","LU0070302665.USD","LU0320765489.SGD","LU1023059063.AUD","LU0234572021.USD","BK4139","LU0058720904.USD","LU0238689110.USD","LU1941712348.USD","SG9999014559.SGD","LU2089984988.USD","LU1093756325.SGD","LU0320765646.SGD","SG9999014542.SGD","BK4550","LU1061106388.HKD","LU1989772923.USD","BK4568","LU0130517989.USD","LU0203345920.USD","IE00BN8TJ469.HKD","LU2324357040.USD","IE00BLSP4452.SGD","LU1699723380.USD","LU1093756168.USD","SG9999001176.USD","LU1291159041.SGD","LU1201861249.SGD","SG9999014575.USD","SG9999015341.SGD","LU2106854487.HKD","LU1066051811.HKD","LU2361044865.SGD","LU0122379950.USD","LU0289739699.SGD","SG9999002224.SGD","SG9999015358.SGD","LU1066053197.SGD","LU0985320562.USD","LU0965509283.SGD","SG9999001176.SGD","LU1571399168.USD","LU1116320901.HKD","IE00BSNM7G36.USD","LU2461242641.AUD","BK4588","LU0265550359.USD","BK4548","IE00B1BXHZ80.USD","BK4516","BK4551","LU1037948541.HKD","SG9999013999.USD","LU1037948897.HKD","SGXZ57979304.SGD","BK4533","LU2361044949.HKD","LU2468319806.SGD","LU0211331839.USD","LU2125154935.USD","SG9999001440.SGD","LU0965509010.AUD","BK4532","BK4559","BK4501","IE00BFTCPJ56.SGD","LU1162221912.USD","LU1934455863.HKD","LU0861579265.USD","LU1116320737.USD","LU1989771016.USD","LU1057294990.SGD","LU0098860793.USD","IE0009355771.USD","LU1917777945.USD","LU0130102774.USD","LU1929549753.HKD","LU1989772840.SGD","LU0980610538.SGD","LU0203347892.USD","LU1974910355.USD","LU0266013472.USD","SG9999002232.USD","LU1983299246.USD"],"gpt_icon":0},{"id":"1175355010","title":"一周美股牛榜 | Moderna周升近22%，预计去年销售额达19亿美元；AMD周升14%，获大行看升至270美元；西部数据涨幅超10%","url":"https://stock-news.laohu8.com/highlight/detail?id=1175355010","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1175355010?lang=zh_cn&edition=full","pubTime":"2026-01-19 10:30","pubTimestamp":1768789819,"startTime":"0","endTime":"0","summary":"Moderna周一表示，预计2025年销售额约为19亿美元，接近此前预测区间16亿至20亿美元的上限，但仍远低于新冠疫情期间实现的收入水平。该机构预计，随着2025年2月21日分拆一周年临近，西部数据将在未来数周内变现其持有的闪迪剩余约5%股份。","market":"us","thumbnail":"https://community-static.tradeup.com/news/b709e81a1b4f7405bf5e343b3c9425a7","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/b709e81a1b4f7405bf5e343b3c9425a7"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"02062fdbced3428c4b67a0fca2c96670","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"一周美股牛榜 | Moderna周升近22%，预计去年销售额达19亿美元；AMD周升14%，获大行看升至270美元；西部...","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMD","GLW","FIX","APH","MRNA","CSGP","JBL","WDC","KLAC","PWR"],"gpt_icon":0},{"id":"1136643252","title":"异动解读 | Moderna盘中大涨5.05%，因上调营收预期及疫苗管线进展","url":"https://stock-news.laohu8.com/highlight/detail?id=1136643252","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1136643252?lang=zh_cn&edition=full","pubTime":"2026-01-14 23:16","pubTimestamp":1768403797,"startTime":"0","endTime":"0","summary":"Moderna（MRNA）今日盘中大涨5.05%，表现亮眼。消息面上，Moderna在摩根大通医疗保健大会上表示，预计2025年营收约为19亿美元，高于此前预期的中值。此外，公司重申2026年营收增长目标为最高10%，并预计年内将获得两款疫苗的监管批准，包括独立流感疫苗和新冠-流感联合疫苗。这些积极信号提振了市场对该公司后疫情时代业务稳定性的信心。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["MRNA"],"gpt_icon":0},{"id":"1112801850","title":"异动解读 | Moderna盘中大涨12.09%，因2025年销售额指引乐观及成本削减","url":"https://stock-news.laohu8.com/highlight/detail?id=1112801850","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1112801850?lang=zh_cn&edition=full","pubTime":"2026-01-14 00:20","pubTimestamp":1768321222,"startTime":"0","endTime":"0","summary":"Moderna, Inc.（MRNA）今日盘中大涨12.09%，成为市场焦点。消息面上，公司预计2025年销售额将达到19亿美元，接近此前预测范围的上限，同时将2025年的运营支出预测削减了2亿美元。此外，公司重申了2026年实现高达10%收入增长的目标，并预计今年将获得独立流感疫苗和COVID流感联合疫苗的监管批准。这些积极的财务预测和监管进展显著提升了市场对Moderna未来业绩的信心，推动了股价的强劲表现。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["MRNA"],"gpt_icon":0},{"id":"1176500565","title":"Moderna盘中大涨12%，预计2025销售额将达指引上限，重申2026增长目标","url":"https://stock-news.laohu8.com/highlight/detail?id=1176500565","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1176500565?lang=zh_cn&edition=full","pubTime":"2026-01-14 00:16","pubTimestamp":1768320970,"startTime":"0","endTime":"0","summary":"将2025年的运营支出预测削减了2亿美元。","market":"us","thumbnail":"https://static.tigerbbs.com/62cb1d74907193576acf6136d51098d6","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/62cb1d74907193576acf6136d51098d6"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRNA"],"gpt_icon":0},{"id":"1133947595","title":"异动解读 | Moderna盘前大涨6.18%，因预计销售额达19亿美元并下调成本预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1133947595","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1133947595?lang=zh_cn&edition=full","pubTime":"2026-01-12 20:06","pubTimestamp":1768219581,"startTime":"0","endTime":"0","summary":"Moderna, Inc. (MRNA) 今日盘前股价大涨6.18%，引起了市场的广泛关注。消息面上，Moderna预计2025年销售额将达到19亿美元，接近此前预测范围的上限，同时将2025年的运营支出预测削减了2亿美元。此外，公司重申了2026年实现高达10%收入增长的目标，并预计今年将获得独立流感疫苗和COVID流感联合疫苗的监管批准。这些积极的财务和运营更新增强了投资者对公司未来增长潜力的信心。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"650860a889e83af5eb15ea72cc36cf6b","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["MRNA"],"gpt_icon":0},{"id":"1146876963","title":"异动解读 | 拜耳起诉专利侵权，Moderna盘中大跌5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=1146876963","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1146876963?lang=zh_cn&edition=full","pubTime":"2026-01-09 02:42","pubTimestamp":1767897738,"startTime":"0","endTime":"0","summary":"Moderna, Inc. (MRNA) 今日盘中大跌5.02%，引发市场关注。消息面上，拜耳公司已对Moderna提起诉讼，指控其侵犯了与mRNA技术相关的知识产权。拜耳声称，Moderna在开发新冠疫苗时使用了拜耳十年前收购的孟山都公司开发的技术，以提高mRNA的稳定性和蛋白质产量。拜耳要求获得疫苗销售收入的一部分以及未来销售的特许权使用费。此次诉讼增加了Moderna面临的法律和财务不确定性，可能导致投资者担忧，从而引发股价下跌。此前，Moderna已卷入多起类似诉讼，包括与GSK和辉瑞/BioNTech的纠纷。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["MRNA"],"gpt_icon":0},{"id":"2601332259","title":"瑞银：首次覆盖Moderna给予中性评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2601332259","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601332259?lang=zh_cn&edition=full","pubTime":"2026-01-07 17:16","pubTimestamp":1767777369,"startTime":"0","endTime":"0","summary":"格隆汇1月7日｜瑞银：首次覆盖Moderna(MRNA.US)，给予中性评级，目标价定为34美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260107171640a4a71757&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260107171640a4a71757&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4534","BK4139","BK4588","BK4532","BK4548","BK4551","BK4568","BK4501","MRNA","BK4533","BK4585"],"gpt_icon":0},{"id":"1155761991","title":"异动解读 | Moderna盘中大涨10.97%，因BofA上调目标价","url":"https://stock-news.laohu8.com/highlight/detail?id=1155761991","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1155761991?lang=zh_cn&edition=full","pubTime":"2026-01-06 23:56","pubTimestamp":1767714986,"startTime":"0","endTime":"0","summary":"Moderna（MRNA）今日盘中大涨10.97%，成为市场焦点。消息面上，BofA全球研究公司上调了Moderna的目标股价，这一举措显著提升了投资者对该股的信心，推动其股价大幅上涨。医疗保健板块整体表现强劲，进一步带动了Moderna的涨势。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"65ea9bea0b0ef90fd686d76394fa8759","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["MRNA"],"gpt_icon":0},{"id":"1127867080","title":"美股生物医药股集体上扬！Moderna涨超7%，Sarepta Therapeutics涨超6%","url":"https://stock-news.laohu8.com/highlight/detail?id=1127867080","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1127867080?lang=zh_cn&edition=full","pubTime":"2026-01-06 23:04","pubTimestamp":1767711863,"startTime":"0","endTime":"0","summary":"1月6日，美股生物医药股集体上扬，$Moderna(MRNA)$涨超7%，$Sarepta Therapeutics(SRPT)$涨超6%，$诺和诺德(NVO)$、$诺瓦瓦克斯医药(NVAX)$涨超5%，$葛兰素史克(GSK)$涨超4%。","market":"us","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"65ea9bea0b0ef90fd686d76394fa8759","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0009355771.USD","IE00B2B36J28.USD","IE00BFTCPJ56.SGD","BK4585","NVO","IE0002141913.USD","MRNA","SRPT","BK4139","IE00BJJMRZ35.SGD","BK4539","IE00BJT1NW94.SGD","BK4007"],"gpt_icon":0},{"id":"1189722170","title":"异动解读 | Moderna流感疫苗提交多国上市申请，盘中大涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=1189722170","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1189722170?lang=zh_cn&edition=full","pubTime":"2026-01-05 22:46","pubTimestamp":1767624383,"startTime":"0","endTime":"0","summary":"Moderna, Inc.（MRNA）今日盘中股价大涨5.02%，引发市场关注。消息面上，Moderna宣布已向美国FDA、欧洲EMA、加拿大卫生部及澳大利亚TGA同步提交其mRNA流感疫苗mRNA-1010的上市授权申请。这一关键进展标志着该疫苗在全球主要市场的监管审批正式启动，若获批将成为公司继新冠疫苗后的又一重磅产品，为季节性流感预防提供创新解决方案。此外，Moderna近期还公布了2025年16亿至20亿美元的营收目标，并强化商业团队建设以推动季节性疫苗业务发展，进一步巩固了投资者对公司长期增长潜力的信心。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["MRNA"],"gpt_icon":0},{"id":"1163124127","title":"Moderna公司：商业团队夯实季节性疫苗业务基础，瞄准2025年16至20亿美元营收目标","url":"https://stock-news.laohu8.com/highlight/detail?id=1163124127","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1163124127?lang=zh_cn&edition=full","pubTime":"2026-01-05 22:19","pubTimestamp":1767622757,"startTime":"0","endTime":"0","summary":"Moderna公司正通过强化商业团队建设，为其季节性疫苗业务奠定坚实基础。公司最新规划显示，其目标是在2025年实现16亿至20亿美元的营收预期区间。\n这一战略部署凸显了该生物技术巨头对疫苗商业化进程的加速推进。随着全球公共卫生体系对呼吸道疫苗需求的持续增长，Moderna正通过优化销售网络、提升市场渗透率等措施，不断增强其在季节性疫苗领域的竞争壁垒。\n值得注意的是，此次公布的营收指引较以往更为具体，反映出公司对核心业务增长轨迹的清晰预判。通过将商业团队建设与产品管线发展相结合，Moderna正在构建一个更具韧性的疫苗生态系统。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4548","MRNA","BK4585","BK4588","BK4533","BK4139","BK4501","BK4551","BK4568","BK4534","BK4532"],"gpt_icon":0},{"id":"1187386977","title":"Moderna, Inc. 目标营收区间锁定16至20亿美元，商业团队夯实季节性疫苗业务基础","url":"https://stock-news.laohu8.com/highlight/detail?id=1187386977","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1187386977?lang=zh_cn&edition=full","pubTime":"2026-01-05 22:11","pubTimestamp":1767622263,"startTime":"0","endTime":"0","summary":"随着其商业团队成功巩固了季节性疫苗产品线的市场基础，Moderna, Inc. 已将未来的营收目标设定在16亿至20亿美元的预期区间内。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4533","BK4548","BK4585","MRNA","BK4588","BK4139","BK4568","BK4532","BK4551","BK4501","BK4534"],"gpt_icon":0},{"id":"1105519242","title":"Moderna向多国监管机构提交流感疫苗mRNA-1010上市申请","url":"https://stock-news.laohu8.com/highlight/detail?id=1105519242","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1105519242?lang=zh_cn&edition=full","pubTime":"2026-01-05 20:13","pubTimestamp":1767615196,"startTime":"0","endTime":"0","summary":"生物技术公司Moderna宣布，其研发的mRNA流感疫苗mRNA-1010已正式向美国食品药品监督管理局（FDA）、欧洲药品管理局（EMA）、加拿大卫生部（Health Canada）以及澳大利亚治疗商品管理局（TGA）提交上市授权申请。这一关键进展标志着该疫苗在全球主要市场的监管审批程序全面启动。\n此次多国同步申报的策略凸显了Moderna对拓展呼吸道疫苗市场的战略布局。若获批，mRNA-1010将成为该公司继新冠疫苗后又一重要商业化产品，有望为季节性流感预防提供创新解决方案。业界密切关注该疫苗在审批过程中的数据表现，其技术路径与传统灭活疫苗的差异化优势或成为监管考量的关键因素。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4551","BK4568","MRNA","BK4532","BK4533","BK4139","BK4501","BK4534","BK4548","BK4585","BK4588"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.modernatx.com","stockEarnings":[{"period":"1week","weight":-0.0953},{"period":"1month","weight":0.4944},{"period":"3month","weight":0.6226},{"period":"6month","weight":0.5964},{"period":"1year","weight":0.0738},{"period":"ytd","weight":0.4944}],"compareEarnings":[{"period":"1week","weight":0.004},{"period":"1month","weight":0.0147},{"period":"3month","weight":0.0145},{"period":"6month","weight":0.113},{"period":"1year","weight":0.1437},{"period":"ytd","weight":0.0147}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Moderna, Inc.于2016年7月22日根据特拉华州法律注册成立。该公司是信使核糖核酸（信使核糖核酸）医学领域的领导者。通过在科学、技术和健康的交叉领域工作十多年，该公司以前所未有的速度和效率开发出药物，包括最早和最有效的新冠疫苗之一。该公司的mRNA平台已使传染病、免疫肿瘤学、罕见病和自身免疫性疾病的疗法和疫苗的开发成为可能。凭借独特的文化和由Moderna价值观和思维模式驱动的全球化团队，以负责任的方式改变人类健康的未来，该公司努力通过mRNA药物向人们传递尽可能大的影响。","yearOnYearQuotes":[{"month":1,"riseRate":0.625,"avgChangeRate":0.112326},{"month":2,"riseRate":0.285714,"avgChangeRate":-0.012362},{"month":3,"riseRate":0.571429,"avgChangeRate":0.028598},{"month":4,"riseRate":0.714286,"avgChangeRate":0.123955},{"month":5,"riseRate":0.571429,"avgChangeRate":0.06219},{"month":6,"riseRate":0.428571,"avgChangeRate":-0.025027},{"month":7,"riseRate":0.714286,"avgChangeRate":0.106584},{"month":8,"riseRate":0.285714,"avgChangeRate":-0.089569},{"month":9,"riseRate":0.571429,"avgChangeRate":-0.018964},{"month":10,"riseRate":0.428571,"avgChangeRate":-0.032236},{"month":11,"riseRate":0.714286,"avgChangeRate":0.206001},{"month":12,"riseRate":0.428571,"avgChangeRate":-0.033274}],"exchange":"NASDAQ","name":"Moderna, Inc.","nameEN":"Moderna, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Moderna, Inc.(MRNA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Moderna, Inc.(MRNA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Moderna, Inc.,MRNA,Moderna, Inc.股票,Moderna, Inc.股票老虎,Moderna, Inc.股票老虎国际,Moderna, Inc.行情,Moderna, Inc.股票行情,Moderna, Inc.股价,Moderna, Inc.股市,Moderna, Inc.股票价格,Moderna, Inc.股票交易,Moderna, Inc.股票购买,Moderna, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Moderna, Inc.(MRNA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Moderna, Inc.(MRNA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}